Why ADHD Feels Different at Different Times of the Month — and Across Your Life

ADHD in females

An evidence-based look at how sex hormones shape ADHD in females, and what a landmark 2025 systematic review tells us about it

First, a Quick Refresher: ADHD Isn't Just a "Boy Thing"

ADHD has long been thought of as a condition that mostly affects boys and men. Statistically, boys are diagnosed at about a 2.4-to-1 ratio compared to girls. But here's the important part: researchers now believe this gap is largely a product of underdiagnosis in females, not a true difference in how often ADHD occurs.

Why does underdiagnosis happen? Think about how ADHD tends to look in males, especially younger boys — lots of visible hyperactivity, running around, interrupting class. That's the "classic" image most people picture. Girls and women with ADHD, on the other hand, often present differently. They're more likely to show up as quietly inattentive, disorganized, emotionally reactive, or struggling with executive function — things that are easier to chalk up to anxiety, depression, or just "being dramatic." By the time many females get diagnosed, they've spent years wondering why life feels so much harder for them than it seems to for everyone else.

And layered on top of that diagnostic delay is something researchers are only beginning to fully appreciate: hormones.

Your Hormones Are Constantly Talking to Your Brain

Estrogen and progesterone — the two main sex hormones in females — aren't just about reproduction. They're powerful neurosteroids that directly influence how your brain works. Think of your brain chemistry like a carefully tuned sound system. Estrogen is like a volume boost for dopamine — the same neurotransmitter that's famously dysregulated in ADHD. It helps stimulate dopamine production, limits how quickly dopamine gets reabsorbed, and essentially helps keep that signal clear and strong.

Progesterone has a more complicated relationship with the system. Depending on where it's acting in the brain and what hormonal environment it's in, it can sometimes support dopamine activity and sometimes dampen it.

Here's why that matters: if you already have ADHD, your dopamine system is already running below optimal. So when estrogen dips — as it does during the premenstrual phase of your cycle, during the postpartum period, or during perimenopause — it's not just that you feel "off." Your underlying ADHD circuitry may be getting significantly less support, making symptoms measurably worse.

What the 2025 Systematic Review Actually Found

Osianlis and colleagues did something that hadn't been done before at this scale: they systematically searched three major medical databases covering 45 years of research (1980 to January 2025) to find every study that examined ADHD and sex hormones in females. Out of more than 4,300 records, only 11 studies qualified for inclusion. That number itself tells you something important about how badly this area has been neglected.

Here's what those 11 studies revealed:

Puberty: A Different Experience for Girls

Three studies looked at ADHD during puberty. The picture that emerged is the opposite of what we see in boys. In males, hyperactivity symptoms tend to improve during puberty — consistent with the well-known pattern of boys "growing out of it." In female rats (and mirrored in human studies), puberty is associated with an increase in dopamine receptors, which may actually amplify ADHD symptoms rather than ease them.

One longitudinal study followed girls with ADHD over 8 years and found that hyperactivity did decrease with pubertal development — but depression increased. Meanwhile, another study found that early pubertal onset was associated with higher inattention scores in adulthood. In other words, puberty isn't the clean turning point for girls that it often is for boys. For many females, it may actually be when ADHD starts to compound.

The Menstrual Cycle: Your Symptoms Have a Pattern

Four studies looked at ADHD across the menstrual cycle, and this is where the evidence gets particularly compelling — even though it's still early-stage.

During the late luteal phase (the week or so before your period), estrogen drops sharply. Multiple studies found this to be a time when ADHD symptoms — especially inattention, emotional dysregulation, and executive dysfunction — worsen noticeably. Women reported that their medication felt less effective during this window too.

One study went further, measuring actual hormone levels across the cycle. It found that when estrogen was low and progesterone was high (the hormonal cocktail of the early luteal phase), women with high trait impulsivity showed a measurable spike in ADHD symptoms. And perhaps most practically: a small study of nine women who were experiencing premenstrual worsening of ADHD tried adjusting their stimulant dose upward during that phase. All nine reported improvement in both ADHD symptoms and mood.

That's a small study, but it points to something clinicians and patients have been quietly figuring out for years — and it's finally getting research attention.

Pregnancy: High Estrogen May Be Protective

Only one study examined ADHD during pregnancy, but the results are thought-provoking. Pregnancy is associated with dramatically elevated estrogen levels. In the study, there were no significant differences in overall ADHD symptom scores between women who continued medication, used it as needed, or stopped it entirely. The researchers raised the possibility that the high-estrogen environment of pregnancy itself may be buffering ADHD symptoms — potentially meaning some women need less medication than usual during this period. That said, this was a very small study of 25 participants, and individual variation matters enormously.

Notably, women who discontinued ADHD medication showed significantly higher depression scores as pregnancy progressed compared to those who maintained it — an important reminder that stopping medication during pregnancy carries its own risks.

PCOS, Testosterone, and an Interesting Signal

Three additional studies examined other hormonal environments. Women with polycystic ovary syndrome (PCOS) — a condition involving elevated androgens like testosterone — showed higher rates of hyperactivity and impulsivity symptoms compared to controls. Interestingly, inattention scores did not differ. This raises the possibility that androgens may specifically drive the hyperactive-impulsive dimension of ADHD, while estrogen is more tied to inattentive symptoms.

One well-designed Mendelian randomization study (essentially a genetics-based tool for testing causal relationships) found no direct causal link between bioavailable testosterone and ADHD risk in females — which suggests the testosterone-ADHD connection in PCOS may be more complex than simple cause and effect.

Menopause: The Biggest Gap in the Research

Here's perhaps the most striking finding of the review: the researchers found zero empirical studies on ADHD and menopause. Zero. Despite the fact that perimenopause involves exactly the kind of declining, fluctuating estrogen levels that the rest of the research suggests should significantly worsen ADHD — and despite the fact that clinicians report many of their female patients describe a dramatic worsening of symptoms during this life stage.

Brain fog, executive dysfunction, trouble with attention and memory — these are commonly reported symptoms of menopause, and they overlap substantially with ADHD. Disentangling the two is genuinely challenging. Some women are being diagnosed with ADHD for the first time during perimenopause, having lived their whole lives with unrecognized symptoms that are now being pushed beyond their coping threshold by hormonal change.

This is a major research gap that urgently needs attention.

What This Means If You Have ADHD

This review doesn't just add academic knowledge. It has real, practical implications.

Your experience is real and valid. If you've noticed your ADHD feels worse at certain times of the month, in the weeks before or after major hormonal events, or during perimenopause — you're not imagining it. The science, though early-stage, is starting to catch up to what women have been reporting for years.

It's worth tracking. If you suspect a hormonal pattern to your ADHD symptoms, consider keeping a simple journal for a couple of months. Note where you are in your cycle alongside your symptom severity, how your medication feels, your mood, and your executive function. This information can be genuinely useful to bring to a prescriber or psychiatrist.

Talk to your doctor about it. Awareness of this connection is still not universal in clinical practice. The researchers specifically recommend that clinicians ask female patients whether they notice symptom fluctuations tied to hormonal phases — and most don't do this routinely yet. You may need to bring it up first. Premenstrual dose adjustment is one evidence-informed option worth discussing.

Hormonal therapies may play a role. While the research isn't definitive yet, hormonal stabilization strategies — like those used in premenstrual dysphoric disorder or menopausal depression — are being explored as potential complements to ADHD treatment. This isn't a DIY recommendation, but it is an emerging clinical frontier worth following.

The Big Picture: A Female Experience of ADHD That We're Only Beginning to Understand

Perhaps the most important contribution of this review is what it reveals about how poorly ADHD in females has been studied. Forty-five years of research, three major medical databases, and only 11 qualifying studies on ADHD and hormones in women. No studies on ADHD during menopause. One study on pregnancy. Most studies with small sample sizes and limited diagnostic rigor.

ADHD research has historically centered male subjects and male presentations. This review is part of a broader wave of researchers calling for a course correction — one that takes the full hormonal life course of females seriously, from puberty through menopause.

Understanding ADHD as a condition that interacts dynamically with a person's hormonal biology isn't just scientifically interesting. It's practically necessary. For the millions of women who were diagnosed late, who've been on and off medication without understanding why it sometimes feels ineffective, who've been told their symptoms were "just PMS" or "just menopause" — this research is the beginning of a more complete explanation.

And that matters.

A Note on the Study

"ADHD and Sex Hormones in Females: A Systematic Review" was published in 2025 in the Journal of Attention Disorders (Vol. 29, No. 9, pp. 706–723) by Elyssa Osianlis, Elizabeth H.X. Thomas, Lisanne Michelle Jenkins, and Caroline Gurvich at HER Centre Australia, Monash University. The review followed PRISMA 2020 guidelines and was pre-registered on PROSPERO. No conflicts of interest were declared.

---

At ADHD Awearness, we're committed to bringing you evidence-based content that reflects the full diversity of ADHD experiences. If this post resonated with you, share it with someone who might need to hear it.